SEC Form 4 · accession 0001127602-17-020590
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregg H Alton
Officer — EVP Comm&Acs ALA, Corp&Med Aff
Period of report
Jun 1, 2017
Accepted (ET)
Jun 5, 2017 · 6:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 1, 2017 | S | 5,000 | $65.0227 | D | 107,988 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
- F2Sale prices reported for the transactions reported here range from $65.01 to $65.05. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.